Hepatitis C/ Human Immunodeficiency Virus Coinfection Clinical Trials

Hepatitis C/ Human Immunodeficiency Virus Coinfection

Explore clinical trials studying Hepatitis C/ Human Immunodeficiency Virus Coinfection. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Hepatitis C/ Human Immunodeficiency Virus Coinfection trial results

Completed

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

NCT02103439

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: State Public Healthcare Institution National Center for the Prevention and Control of AIDS and other infectious diseases of the Ministry of Health of the Republic of Tatarstan Kazan', Tatarstan Republic, Russia

State Institution of Nizhny Novgorod region "Regional Center for Prevention and Control of AIDS and other infectious diseases" Nizhny Novgorod, Russia

State Healthcare Institution Center for the Prevention and Control of AIDS and infectious diseases of the city, St.Petersburg CityHealth Department Saint Petersburg, Russia

State Budgetary Higher Vocational Education Institution V.I. Razumovsky Saratov State University of medicine Saratov, Russia

View Trial Details

Related conditions